Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex

Jon S. Zawistowski, Samantha M. Bevill, Daniel R. Goulet, Timothy J. Stuhlmiller, Adriana S. Beltran, Jose F. Olivares-Quintero, Darshan Singh, Noah Sciaky, Joel S. Parker, Naim U. Rashid, James S. Duncan, Martin C. Whittle, Steven P. Angus, Sara Hanna Velarde, Brian T. Golitz, Xiaping He, Charlene Santos, David B. Darr, Kristalyn Gallagher, Lee M. GravesCharles M. Perou, Lisa A. Carey, H. Shelton Earp, Gary L. Johnson

Research output: Contribution to journalArticlepeer-review

124 Scopus citations

Fingerprint

Dive into the research topics of 'Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology